Circadian system — A novel diagnostic and therapeutic target in Parkinson's disease?
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
The circadian system regulates biological rhythmicity in the human body. The role of the circadian system in neurological disorders is a theme that is attracting an increasing amount of interest from the scientific community. This has arisen, in part, from emerging evidence that disorders such as Parkinson's disease (PD) are multifactorial with many features exhibiting diurnal fluctuations, thereby suggestive of circadian involvement. Although the importance of fluctuating motor and nonmotor manifestations in PD have been well acknowledged, the role of the circadian system has received little attention until recently. It is proposed that intervening with circadian function provides a novel research avenue down which new strategies for improving symptomatic treatment and slowing of the progressive degenerative process can be approached to lessen the burden of PD. In this article we review the literature describing existing circadian research in PD and its experimental models. © 2016 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transplanted Suprachiasmatic Nucleus Determines Circadian Period
Ralph, M. R., Foster, R. G., Davis, F. C., & Menaker, M. (1990) · Science · doi:10.1126/science.2305266 · Cited by 1,853
The genetics of mammalian circadian order and disorder: implications for physiology and disease
Takahashi, J. S., Hong, H.-K., Ko, C. H., & McDearmon, E. L. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2430 · Cited by 1,611 · cited 1×
“2).(7) Aging is associated with changes in the circadian”
BackgroundBright light resets the human circadian pacemaker independent of the timing of the sleep-wake cycle
Czeisler, C. A., Allan, J. S., Strogatz, S. H., Ronda, J. M., Sánchez, R., Ríos, C. D., Freitag, W. O., Richardson, G. S., & Kronauer, R. E. (1986) · Science · doi:10.1126/science.3726555 · Cited by 770 · cited 1×
“Circadian rhythms are synchronized with the solar day by “zeitgebers,” of which light is the most important and potent stimulus.(60,61) This synchronization ensures that behavioral, physiologic, and genetic rhythms are timed appropriately with daily changes in the environment and with each other.”
BackgroundHypocretin (orexin) loss in Parkinson's disease
Fronczek, R., Overeem, S., Lee, S. Y. Y., Hegeman, I. M., van Pelt, J., van Duinen, S. G., Lammers, G. J., & Swaab, D. F. (2007) · Brain · doi:10.1093/brain/awm090 · Cited by 463
The Nighttime Problems of Parkinsonʼs Disease
Lees, A. J., Blackburn, N. A., & Campbell, V. L. (1988) · Clinical Neuropharmacology · doi:10.1097/00002826-198812000-00004 · Cited by 444
Sleep and Circadian Rhythm Regulation in Early Parkinson Disease
Breen, D. P., Vuono, R., Nawarathna, U., Fisher, K., Shneerson, J. M., Reddy, A. B., & Barker, R. A. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.65 · Cited by 440
Association of sleep-wake habits in older people with changes in output of circadian pacemaker
Czeisler, C. A., Dumont, M., Duffy, J. F., Steinberg, J. D., Richardson, G. S., Brown, E. N., Sánchez, R., Ríos, C. D., & Ronda, J. M. (1992) · The Lancet · doi:10.1016/0140-6736(92)92817-y · Cited by 437
Circadian clocks: regulators of endocrine and metabolic rhythms
Hastings, M., O’Neill, J. S., & Maywood, E. S. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0378 · Cited by 426
Circadian Melatonin Rhythm and Excessive Daytime Sleepiness in Parkinson Disease
Videnovic, A., Noble, C., Reid, K. J., Peng, J., Turek, F. W., Marconi, A., Rademaker, A. W., Simuni, T., Zadikoff, C., & Zee, P. C. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6239 · Cited by 390 · cited 4×
“This will be especially important in clinical investigations, as only a few circadian studies to date have employed controlled experimental conditions with rigor in the PD population.(51,55,56) A dedicated attention to these methodological aspects in this area of PD research will allow us to determine if changes in ci…”
BackgroundResultInfluentialNeuroendocrine rhythms and sleep in aging men
van Coevorden, A., Mockel, J., Laurent, E., Kerkhofs, M., L'Hermite-Baleriaux, M., Decoster, C., Neve, P., & Van Cauter, E. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.4.e651 · Cited by 336
Hood, S., Cassidy, P., Cossette, M.-P., Weigl, Y., Verwey, M., Robinson, B., Stewart, J., & Amir, S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2128-10.2010 · Cited by 246 · cited 3×
“Unilateral depletion of dopamine by 6-OHDA injection into the medial forebrain results in blunting of daily expression of the clock protein PERIOD2 (PER2) in the dorsal striatum of rat.(72) Timed daily activation of D2 receptors restores and entrains the PER2 rhythms in the DAdepleted striatum.”
BackgroundCircadian dysfunction in a mouse model of Parkinson's disease
Kudo, T., Loh, D. H., Truong, D., Wu, Y., & Colwell, C. S. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.003 · Cited by 188 · cited 2×
“Using the alpha-synuclein-overexpressing (ASO) transgenic mouse model of PD, Kudo and colleagues demonstrated impaired circadian locomotion rhythm with lower nighttime activity, greater fragmentation in wheel-running activity, and impaired sleep.(80) These changes progressively worsened with age.”
BackgroundSleep Disruption in Parkinson's Disease: Assessment by Continuous Activity Monitoring
van Hilten, B. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210094018 · Cited by 166 · cited 1×
“Increased levels of physical activity and shorter periods of immobility during the night are reported to result in an almost flat diurnal pattern of motor activity in these patients.(19,20) Examination of the circadian pattern of motor symptoms in PD also reveals progressive deterioration in motor function as the day…”
BackgroundBright light therapy in Parkinson's disease: a pilot study
Paus, S., Schmitz‐Hübsch, T., Wüllner, U., Vogel, A., Klockgether, T., & Abele, M. (2007) · Movement Disorders · doi:10.1002/mds.21542 · Cited by 162
Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease
Bolitho, S. J., Naismith, S. L., Rajaratnam, S. M. W., Grunstein, R. R., Hodges, J. R., Terpening, Z., Rogers, N., & Lewis, S. J. G. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2013.10.016 · Cited by 139 · cited 2×
“This will be especially important in clinical investigations, as only a few circadian studies to date have employed controlled experimental conditions with rigor in the PD population.(51,55,56) A dedicated attention to these methodological aspects in this area of PD research will allow us to determine if changes in ci…”
BackgroundResultDiurnal effects of motor activity and fatigue in Parkinson's disease.
van Hilten, J. J., Hoogland, G., van der Velde, E. A., Middelkoop, H. A., Kerkhof, G. A., & Roos, R. A. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.8.874 · Cited by 105 · cited 1×
“Increased levels of physical activity and shorter periods of immobility during the night are reported to result in an almost flat diurnal pattern of motor activity in these patients.(19,20) Examination of the circadian pattern of motor symptoms in PD also reveals progressive deterioration in motor function as the day…”
BackgroundLoss of dopamine disrupts circadian rhythms in a mouse model of Parkinson's disease
Fifel, K., & Cooper, H. M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.024 · Cited by 80 · cited 1×
“In this model of PD, a gradual agedependent decline in the amplitude and the stability of rest-activity rhythms starts around 20 weeks of age.(83) Exposure to constant darkness or light challenges the circadian system and results in severe disturbance or complete loss of locomotion rhythms in MITOPARK mice, whereas th…”
BackgroundDiurnal motor variations to repeated doses of levodopa in Parkinson's disease
Bonuccelli, U., Del Dotto, P., Lucetti, C., Petrozzi, L., Bernardini, S., Gambaccini, G., Rossi, G., & Piccini, P. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200001000-00006 · Cited by 79
Gravotta, L., Gavrila, A. M., Hood, S., & Amir, S. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9520-8 · Cited by 74 · cited 3×
“6-OHDA-lesioned rats housed in constant darkness were less active and had disorganized patter of wheel-running activity.(73) None of the above manipulations, however, affected the PER2 rhythm in the SCN.”
BackgroundEffects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study
Boulamery, A., Simon, N., Vidal, J., & Bruguerolle, B. (2010) · Chronobiology International · doi:10.3109/07420521003664213 · Cited by 38 · cited 1×
“Subsequent administration of levodopa resulted in the recovery of the abolished circadian rhythms but without simultaneous improvements in the mesor of temperature and locomotion rhythms.(67) Similarly, employing the unilateral 6-OHDA PD model, lesioned animals had reduced locomotor activity, whereas the overall diurn…”
MethodHineno, T., Mizobuchi, M., Hiratani, K., Inami, Y., & Kakimoto, Y. (1992) · Brain Research · doi:10.1016/0006-8993(92)90930-8 · Cited by 34 · cited 2×
“Although several hormonal circadian markers were tested, only the rhythms of urine volume and vasopressin were altered.(74) The urine volume disappeared 2 weeks after MPTP treatment, and the rhythm of vasopressin remained severely blunted.”
BackgroundResultPlacidi, F., Izzi, F., Romigi, A., Stanzione, P., Marciani, M. G., Brusa, L., Sperli, F., Galati, S., Pasqualetti, P., & Pierantozzi, M. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0836-4 · Cited by 21 · cited 1×
“Objective measures of sleep quality demonstrate alterations in sleep-wake cycles in early, de novo patients with PD.(42) Disrupted sleep and alertness have been associated with more than a 3-fold increase in the risk of developing PD.”
Background
Cited by
Stefani, A., & Högl, B. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0448-y · Cited by 274
Circadian rhythms in neurodegenerative disorders
Nassan, M., & Videnovic, A. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00577-7 · Cited by 253
Self-citationCircadian disruption and sleep disorders in neurodegeneration
Shen, Y., Lv, Q.-K., Xie, W.-Y., Gong, S.-Y., Zhuang, S., Liu, J.-Y., Mao, C.-J., & Liu, C.-F. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00340-6 · Cited by 171
“It is reasonable to link the symptom fluctuations in PD patients with dysregulation of circadian rhythms affected by chronobiology [19].”
BackgroundDiet in Parkinson’s Disease: Critical Role for the Microbiome
Jackson, A., Forsyth, C. B., Shaikh, M., Voigt, R. M., Engen, P. A., Ramirez, V., & Keshavarzian, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01245 · Cited by 145
“Patients with PD have poor sleep and reversal of sleep/wake cycles that can cause disruption of circadian rhythms (129, 130) and both disrupted sleep and circadian disruption can cause dysbiotic microbiota in both humans and rodents (131, 132).”
BackgroundCircadian dysregulation in Parkinson's disease
Videnovic, A., & Golombek, D. (2017) · Neurobiology of Sleep and Circadian Rhythms · doi:10.1016/j.nbscr.2016.11.001 · Cited by 63
“The role of circadian disruption has only recently started to emerge as an important etiology of impaired sleep and alertness in PD (Videnovic and Willis, 2016).”
Background
Metadata
- Authors
- Videnovic, A., & Willis, G. L.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2016-01-30
- Volume
- 31
- Issue
- 3
- Pages
- 260-269
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2284370343
- Cited by
- 114
- References
- 22
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.